Metabotropic actions of kainate receptors modulating glutamate release

Neuropharmacology. 2021 Oct 1:197:108696. doi: 10.1016/j.neuropharm.2021.108696. Epub 2021 Jul 15.

Abstract

Presynaptic kainate (KA) receptors (KARs) modulate GABA and glutamate release in the central nervous system of mammals. While some of the actions of KARs are ionotropic, metabotropic actions for these receptors have also been seen to modulate both GABA and glutamate release. In general, presynaptic KARs modulate glutamate release through their metabotropic actions in a biphasic manner, with low KA concentrations producing an increase in glutamate release and higher concentrations of KA driving weaker release of this neurotransmitter. Different molecular mechanisms are involved in this modulation of glutamate release, with a G-protein independent, Ca2+-calmodulin adenylate cyclase (AC) and protein kinase A (PKA) dependent mechanism facilitating glutamate release, and a G-protein, AC and PKA dependent mechanism mediating the decrease in neurotransmitter release. Here, we describe the events underlying the KAR modulation of glutamatergic transmission in different brain regions, addressing the possible functions of this modulation and proposing future research lines in this field. This article is part of the special Issue on 'Glutamate Receptors - Kainate receptors'.

Keywords: G protein; Glutamate; Kainate receptors; Metabotropic; Presynaptic; Protein kinase A; Protein kinase C.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Glutamic Acid / metabolism*
  • Humans
  • Receptors, Kainic Acid / drug effects
  • Receptors, Kainic Acid / metabolism*
  • Receptors, Metabotropic Glutamate / drug effects
  • Receptors, Metabotropic Glutamate / metabolism*
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Receptors, Kainic Acid
  • Receptors, Metabotropic Glutamate
  • Glutamic Acid
  • gamma-Aminobutyric Acid